Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/30/2003 | US20030023149 Microfluidic microorganism detection system |
01/30/2003 | US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
01/30/2003 | US20030023073 Growth differentiation factor-15 |
01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
01/30/2003 | US20030023069 Endogenous and non-endogenous versions of human G protein-coupled receptors |
01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
01/30/2003 | US20030022868 Selective androgen receptor modulators and methods of use thereof |
01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
01/30/2003 | US20030022853 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
01/30/2003 | US20030022822 Novel compounds |
01/30/2003 | US20030022813 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
01/30/2003 | US20030022812 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
01/30/2003 | US20030022393 Apparatus for in generation surface-mounted optics and material surfaces |
01/30/2003 | US20030022390 Method and kit for making interfering substances in urine undetectable |
01/30/2003 | US20030022387 Method and apparatus for detecting physicochemical changes emitted by biological sample |
01/30/2003 | US20030022385 Threshold glucose detection in urine |
01/30/2003 | US20030022384 Method for screening crystallization conditions in solution crystal growth |
01/30/2003 | US20030022381 Methods for detecting pregnancy |
01/30/2003 | US20030022370 Magnetic immobilization of cells |
01/30/2003 | US20030022352 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein |
01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
01/30/2003 | US20030022340 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022330 APOA2-interacting proteins and use thereof |
01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
01/30/2003 | US20030022305 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides |
01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
01/30/2003 | US20030022270 Automated epifluorescence microscopy for detection of bacterial contamination in platelets |
01/30/2003 | US20030022269 Monitoring chemotaxis of cells; obtain cells, insert into container, expose to substrate, monitor migration of cells |
01/30/2003 | US20030022268 Method and apparatus for patch-clamp measurements on cells |
01/30/2003 | US20030022267 Monitoring the physiological effect of a composition on animal; obtain animal, administer moulator, record physiological adjustments |
01/30/2003 | US20030022263 ATM kinase modulation for screening and therapies |
01/30/2003 | US20030022262 Methods of detecting early renal disease in animals |
01/30/2003 | US20030022259 Method for immunologically measuring RCAS1 and kit for measuring the same |
01/30/2003 | US20030022256 Detection and analysis of preferential cells in sample; obtain cells, incubate with antibodies, activate complement cascade, measure inactive complement peptide present |
01/30/2003 | US20030022255 Novel compositions and methods for breast cancer |
01/30/2003 | US20030022253 Method for identifying, isolating and producing neuroactive binding agents and binding agents derived thereby |
01/30/2003 | US20030022252 Method for identifying tolerance in graft recipients |
01/30/2003 | US20030022251 Gamma-secretase in vitro screening assay |
01/30/2003 | US20030022250 Functional IgE test methods and compositions |
01/30/2003 | US20030022249 Culturing dendritic cells; obtain cell pools, incubate with affinity column, elute, recover preferential cells |
01/30/2003 | US20030022248 Accuracte detection and classification of preferential meat proteins; obtain meat sample with monoclonal antibody, monitor binding, evaluate bonding profile |
01/30/2003 | US20030022246 Method for conducting a receptor-ligand association reaction and apparatus used therefor |
01/30/2003 | US20030022245 Kits for use in the detection, prevention and treatment of bacterial and immunological disorders |
01/30/2003 | US20030022243 Protein aggregation assays and uses thereof |
01/30/2003 | US20030022241 Detection of modulators of enzyme activity; obtain sample containing kinase activity, incubate with modulator, monitor diabetic response |
01/30/2003 | US20030022239 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
01/30/2003 | US20030022237 Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung |
01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
01/30/2003 | US20030022235 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
01/30/2003 | US20030022233 Screening for modulator of tumor necrosis factor activity; obtain sample containing tumor necrosis factor binding protein, incubate with modulator, monitor release of tumor necrosis factor from binding protein |
01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
01/30/2003 | US20030022227 Hybridization substrate for use in genome analysis and bacterial detection |
01/30/2003 | US20030022225 Releasable nonvolatile mass-label molecules |
01/30/2003 | US20030022224 Monitoring binding activity of preferential proteins; obtain sample, incubate with substrate, monitor intensity of fluorescence from labeled protein, adjustment in intensity indicates activity between protein and substrate |
01/30/2003 | US20030022222 HADHs as modifiers of the p21 pathway and methods of use |
01/30/2003 | US20030022220 Methods and compositions for modulating adenosine triphosphate (ATP) in cells and preventing cell injury or death via post-translational modifications to ATP synthase |
01/30/2003 | US20030022216 Functional surface coating |
01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
01/30/2003 | US20030022209 ADSLs as modifiers of the p53 pathway and methods of use |
01/30/2003 | US20030022203 Cellular Arrays |
01/30/2003 | US20030022202 Amino acid sequences for use in the treatment of inflammation and autoimmune diseases |
01/30/2003 | US20030022198 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
01/30/2003 | US20030022197 Device for monitoring haptotaxis |
01/30/2003 | US20030022189 Linker for use in the generation of solid support for analysis of biopolymers |
01/30/2003 | US20030022188 Compositions and methods relating to colon specific genes and proteins |
01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022185 Secreted protein HLHFP03 |
01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
01/30/2003 | US20030022178 Identification of sortase gene |
01/30/2003 | US20030022177 Single-labeled oligonucleotide probes for homogeneous nucleic acid sequence analysis |
01/30/2003 | US20030022174 Cancer diagnostic method using P40 subunit of EIF3 |
01/30/2003 | US20030022173 Isolating nucleotide sequence probes which bind to activated transcription factors; obtain sample, incubate with probes, form complexes, separate complexes, recover bound probes |
01/30/2003 | US20030022172 Polyamide nucleic acid derivatives and agents and processes for preparing them |
01/30/2003 | US20030022171 Detection of modulator of amyloid precursor protein cleavage; obtain cells, incubate with modulator, detect adjustment in amyloid precursor protein, adjustment in protein indicates modulator |
01/30/2003 | US20030022166 Repeat-free probes for molecular cytogenetics |
01/30/2003 | US20030022161 Diagnosing mammary gland cancer in humans; obtain ductal fluid sample, monitor marker gene product expression, amplified concentrations of marker products indicates cancer |
01/30/2003 | US20030022160 Method for the rapid detection of whole microorganisms on retaining membranes by use of chaotropic agents |
01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
01/30/2003 | US20030022157 Methods of producing a library and methods of selecting polynucleotides of interest |
01/30/2003 | US20030022155 Nucleotide sequences for use in the detection of viral disease |
01/30/2003 | US20030022154 Lipid structures and uses thereof |
01/30/2003 | US20030022153 Monitoring migration of preferential particles; obtain cell solution, insert into container, monitor and evaluate migration of cells |
01/30/2003 | US20030022152 Detection of preferential nutrient broths; obtain nurient fluid, monitor and measure indicator, classify broth |
01/30/2003 | US20030022151 Functional screening |